USFDA Slaps Import Alert on Dabur's Silvassa Plant, Stock Treads Water Amid Rally
Dabur India faces fresh regulatory heat as the USFDA issued an import alert against drugs manufactured at its Silvassa facility, restricting US-bound shipments. The stock opened at ₹422.15 and traded in a tight ₹420.45–₹428.80 band on June 12, lagging a broader market rally as investors weigh the export hit on the FMCG major.
USFDA issued an import alert for drugs manufactured at Dabur India's Silvassa plant, keeping the FMCG major's stock flat on June 12 despite a broader market rally. Investors are cautious about regulatory exposure on the company's US-bound shipments.